153 related articles for article (PubMed ID: 10761054)
1. Biology of the Transition of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma.
Lust JA; Donovan KA
Cancer Control; 1998 May; 5(3):209-217. PubMed ID: 10761054
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-1 beta in the pathogenesis of multiple myeloma.
Lust JA; Donovan KA
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1117-25. PubMed ID: 10626139
[TBL] [Abstract][Full Text] [Related]
3. Role of cytokines in the pathogenesis of monoclonal gammopathies.
Lust JA
Mayo Clin Proc; 1994 Jul; 69(7):691-7. PubMed ID: 8015336
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.
Greipp PR; Lust JA
Stem Cells; 1995 Aug; 13 Suppl 2():10-21. PubMed ID: 8520496
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins.
Bosseboeuf A; Allain-Maillet S; Mennesson N; Tallet A; Rossi C; Garderet L; Caillot D; Moreau P; Piver E; Girodon F; Perreault H; Brouard S; Nicot A; Bigot-Corbel E; Hermouet S; Harb J
Front Immunol; 2017; 8():1347. PubMed ID: 29098000
[TBL] [Abstract][Full Text] [Related]
7. Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma.
Lacy MQ; Donovan KA; Heimbach JK; Ahmann GJ; Lust JA
Blood; 1999 Jan; 93(1):300-5. PubMed ID: 9864174
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
9. Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
Donovan KA; Lacy MQ; Kline MP; Ahmann GJ; Heimbach JK; Kyle RA; Lust JA
Leukemia; 1998 Apr; 12(4):593-600. PubMed ID: 9557619
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Sati HI; Apperley JF; Greaves M; Lawry J; Gooding R; Russell RG; Croucher PI
Br J Haematol; 1998 May; 101(2):287-95. PubMed ID: 9609524
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathies of undetermined significance.
Kyle RA; Rajkumar SV
Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
[TBL] [Abstract][Full Text] [Related]
12. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
[TBL] [Abstract][Full Text] [Related]
14. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
Stelmach-Gołdyś A; Czarkowska-Paczek B
Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
[TBL] [Abstract][Full Text] [Related]
16. Paraproteinaemias: pathophysiology.
Samson D
Schweiz Med Wochenschr; 2000 Nov; 130(44):1643-8. PubMed ID: 11103434
[TBL] [Abstract][Full Text] [Related]
17. Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.
Xiong Y; Donovan KA; Kline MP; Gornet MK; Moon-Tasson LL; Lacy MQ; Dispenzieri A; Gertz MA; Greipp PR; Lust JA
J Interferon Cytokine Res; 2006 Feb; 26(2):83-95. PubMed ID: 16487028
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal gammopathies of undetermined significance].
Krizalkovicová V; Maisnar V; Pour L; Radocha J; Hájek R
Klin Onkol; 2008; 21(4):160-4. PubMed ID: 19102222
[TBL] [Abstract][Full Text] [Related]
20. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?
Spira D; Weisel K; Brodoefel H; Schulze M; Kaufmann S; Horger M
Acad Radiol; 2012 Jan; 19(1):89-94. PubMed ID: 22142681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]